As a CEO, you’re accustomed to pressure, tension, and managing complexity. You lean into discomfort; you push through doubts. But what if the most dangerous hesitation isn’t the one you feel—it’s the one you don’t feel? The silent slide away from uncertainty, the rationalisation of risk, the decision that seems fine because discomfort was smoothed over rather than confronted. That’s the domain of the cortisol feedback loop: a loop of avoidance under discomfort that subtly steers decisions long before the boardroom even knows it.
While the dopamine loop, Reward-Driven Momentum, is about how alignment creates conviction too soon, the cortisol loop flips the script: it’s about how discomfort gets softened, how red flags shrink, how tension becomes the cost of moving forward rather than the signal to stop or reassess.
How the Loop Works
Every cortisol loop unfolds in three stages: trigger, response, and reinforcement.
The trigger is often subtle — a number that doesn’t quite add up, a hesitation in a partner’s tone, a lagging milestone that shouldn’t be lagging. You feel a brief flicker of tension — not alarm, just that quiet “something’s off.”
The response comes fast. Your system releases a small dose of cortisol. It doesn’t feel like stress; it feels like restlessness, impatience, the urge to move past the discomfort. Your mind starts talking you out of it: “It’s early,” “This always happens,” “We’ve handled worse.” The logic feels rational, but what you’re really doing is lowering the discomfort enough to keep moving. Relief replaces awareness.
Then comes reinforcement. Because the relief feels good, the brain learns the pattern: tension → rationalisation → ease. Each repetition strengthens the shortcut. You stop treating friction as a signal to investigate and start treating it as background noise. The decision feels smoother, cleaner — but not because the risk disappeared; it’s because you stopped feeling it.
Over time, this quiet chemistry shapes your leadership reflexes. The mind stays focused, confident, and calm — yet slightly detached from the edges of reality. The unease that should prompt scrutiny instead becomes a cue to move forward. Momentum remains — but precision slips.
Related article: Read how this loop fits within the broader Neurochemical Decision Cycle — the three-stage model that explains how chemistry shapes decision-making, daily execution, recovery, and rest.
Why It Matters (and Why It’s Hard to Spot)
This loop rarely looks like avoidance. It looks like confidence, responsiveness, and momentum.
When David, CEO of a software company, agreed to build a new product at a trusted client’s request, the decision felt like a partnership — not a risk. The dopamine loop fired immediately: validation from a valued relationship, alignment with existing capability, early signs of interest from others. Each nod of encouragement released another hit of reward, reinforcing belief in the opportunity before it was tested.
When the uncomfortable truths emerged — limited demand, low pricing tolerance, entrenched competitors — the cortisol loop took over. The tension was felt, but it didn’t last. Each doubt was rationalised away: “We’ve already invested too much,” “The market will open up,” “Even a small foothold is progress.” The discomfort eased, and the decision stayed intact.
Together, the loops built a powerful illusion of control: dopamine kept attention on confirming evidence; cortisol softened contradiction until it felt manageable. What looked like persistence was chemistry protecting comfort.
That’s what makes this pattern so dangerous for leaders. It doesn’t arrive as recklessness or denial — it arrives as conviction. And conviction, unexamined, keeps projects alive long after logic has run out of room.
The real discipline is recognising the loop before it completes — when confidence feels strongest and discomfort feels easiest to explain away.
The Blind Spots That Come With It
When avoidance becomes your habit, you may still feel like a leader in motion—but you’re moving under chemical cover, not clear reasoning. Because discomfort has been neutralised, you stop asking: “What are we missing?” Instead, you move based on “What do we want to believe?”
This creates a set of blind spots:
- Risks feel manageable rather than urgent.
- Contradictory signals are re-interpreted rather than interrogated.
- Momentum is preserved at the cost of accuracy.
- Corrections happen later, under cost and urgency, rather than sooner under clarity.
In effect, the system protects the decision rather than the outcome.
Why This Matters for CEOs
At the executive level, you already know the stakes. You’ve made decisions under ambiguity, led through transitions, and built momentum when others hesitated. What you might not realise is how much of that momentum came on autopilot. You don’t lose deals because you hesitate too much. You lose them when your system never recognises that you should pause.
By understanding the cortisol feedback loop, you reclaim the power of scrutiny: not as indecision, but as precision. You don’t trade speed for carefulness—you trade unconscious motion for intentional motion.
When you regulate this loop, you don’t lose speed—you invest it at the right inflexion points. You don’t abandon momentum—you preserve it for when it matters most.
See If This Loop Is Driving You
If you’re curious about how much avoidance under discomfort is influencing your decisions, the Decision Excellence Assessment includes a measure for exactly that. It maps how the cortisol loop is shaping your judgment, how strongly it shifts what you examine, and how often it delays the pause your system should take.
To explore how your decisions feel and how they’re engineered by chemistry, you can take the assessment here.
Tomasz Drybala – Author, Researcher, Coach, and Director of the Neuro-Based Leadership Centre
My work is grounded in lived experience, research, and ongoing studies with more than 100 CEOs and senior executives — examining how dopamine–cortisol dynamics influence decision-making, execution, and recovery under pressure.
My academic development now includes targeted programs at Harvard, Cambridge, Oxford, and the University of California, Berkeley. I am pursuing a Master’s and — fingers crossed — a PhD in Applied Neuroscience, specialising in decision-making.
I’m also the author of three forthcoming books exploring the neurochemistry of leadership, including Breaking Patterns (September 2026), Neuroscience of CEO Decision-Making (January 2027), and Choosing the Right People (March 2027).